Provided by Tiger Trade Technology Pte. Ltd.

Inovio Pharmaceuticals

1.18
-0.0300-2.48%
Post-market: 1.190.0099+0.84%19:59 EDT
Volume:5.02M
Turnover:5.94M
Market Cap:121.54M
PE:-1.14
High:1.24
Open:1.23
Low:1.15
Close:1.21
52wk High:2.98
52wk Low:0.5632
Shares:103.00M
Float Shares:95.79M
Volume Ratio:0.73
T/O Rate:5.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0338
EPS(LYR):-1.8117
ROE:-409.87%
ROA:-84.23%
PB:27.81
PE(LYR):-0.65

Loading ...

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 26

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 24

Inovio reports pDFVIII DNA therapy corrects bleeding in hemophilia A mice

Reuters
·
Mar 24

Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims

TIPRANKS
·
Mar 23

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 21

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 19

Inovio’s Earnings Call: INO-3107 Drives 2026 Focus

TIPRANKS
·
Mar 18

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 17

Inovio Pharmaceuticals CEO and CFO face securities class action as control person defendants

Reuters
·
Mar 17

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 14

Piper Sandler Sticks to Its Buy Rating for Inovio Pharmaceuticals (INO)

TIPRANKS
·
Mar 13

Inovio Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 13

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 12

Inovio Pharmaceuticals Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
Mar 11

Inovio Pharmaceuticals Inc. published an update to their financial calendar

Reuters
·
Mar 06

Rosen Law Firm Urges Inovio Investors to Act Before April 7 Lead Plaintiff Deadline

Reuters
·
Mar 05

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 05

Inovio Faces Securities Class Action Lawsuit Over FDA Review Timeline Disclosure

Reuters
·
Mar 04

Akeso, INOVIO team up to test cadonilimab plus INO-5412 in GBM trial

Reuters
·
Mar 04

Inovio, Akeso announce clinical collaboration

TIPRANKS
·
Mar 04